1
Oct 13 (Reuters) – Cognition Therapeutics Inc: * COGNITION THERAPEUTICS ANNOUNCES ISSUANCE OF COMPOSITION OF MATTER PATENT, EXTENDING PROTECTION FOR ZERVIMESINE (CT1812) THROUGH 2045 * COGNITION
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
